Evidence map›Paper›PMID 35296314›Full record

ArticleBMC complementary medicine and therapies2022

In vivo assessment of the antimalarial activity and acute oral toxicity of an ethanolic seed extract of Spondias pinnata (L.f.) Kurz.

Prapaporn Chaniad, Arisara Phuwajaroanpong, Walaiporn Plirat, Tachpon Techarang, Arnon Chukaew, Chuchard Punsawad

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Fabrication of Phytosome with Enhanced Activity ofInternational journal of nanomedicine · 2024
    Article
  5. Article
  6. Article
  7. Heliyon · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Prapaporn ChaniadDepartment of Medical Science, School of Medicine, Walailak University, Nakhon Si Thammarat, 80160, Thailand.
Arisara PhuwajaroanpongDepartment of Medical Science, School of Medicine, Walailak University, Nakhon Si Thammarat, 80160, Thailand.
Walaiporn PliratDepartment of Medical Science, School of Medicine, Walailak University, Nakhon Si Thammarat, 80160, Thailand.
Tachpon TecharangDepartment of Medical Science, School of Medicine, Walailak University, Nakhon Si Thammarat, 80160, Thailand.
Arnon ChukaewChemistry Department, Faculty of Science and Technology, Suratthani Rajabhat University, Surat Thani, 84100, Thailand.
Chuchard PunsawadDepartment of Medical Science, School of Medicine, Walailak University, Nakhon Si Thammarat, 80160, Thailand. chuchard.pu@wu.ac.th.
Walailak University · THSuratthani Rajabhat University · TH

Funding

Thailand Science Research and Innovation Fund WU-FF64103
6 · The paper itself

Abstract

backgroundIn response to the persistent problem of malaria resistance, medicinal herbal plants can be used as a source of potential novel antimalarial agents. Therefore, the aim of this study was to evaluate the in vivo antimalarial activity and toxicity of an ethanolic seed extract of Spondias pinnata (L.f.) Kurz (S. pinnata).

methodsQualitative phytochemical screening of the extract was performed using standard procedures, and the constituents were determined by gas chromatography-mass spectrometry (GC-MS). The in vivo antimalarial activity was assessed against the Plasmodium berghei ANKA strain in mice based on 4-day suppressive, curative and prophylactic tests. In addition, the acute toxicity of the extract was evaluated after oral administration of a single dose of 2,000 mg/kg body weight.

resultsPhytochemical screening tests on the ethanolic S. pinnata seed extract revealed the presence of terpenoids, tannins, and coumarins. GC-MS analysis of the extract led to the identification of twenty-nine phytochemical compounds, including oleic acid amide, β-sitosterol, linoleic acid, oleic acid, protocatechuic acid, syringic acid and gallic acid. The results of the 4-day suppressive test revealed that mice treated with 250, 500, 600 and 800 mg/kg doses of the ethanolic S. pinnata seed extract showed significant parasitemia suppression in a dose-dependent manner, with 22.94, 49.01, 60.67 and 66.82% suppression, respectively, compared to that of the negative control group. All the doses of the ethanolic seed extract significantly suppressed parasitemia (P < 0.05) during the curative activity test and prolonged the mean survival time compared to those of the negative control group. However, the ethanolic seed extract displayed lower curative and prophylactic activities than the standard drug artesunate. In addition, the ethanolic seed extract showed no signs of toxicity in mice at a dose of 2,000 mg/kg body weight.

conclusionThe S. pinnata seed extract contains various phytochemical compounds with important medicinal properties. The extract showed a significant suppression of parasitemia in a dose-dependent manner, prolonged the mean survival time and exhibited significant curative and prophylactic activities. The overall results of this study demonstrated that the S. pinnata seed extract possessed promising in vivo antimalarial activity against P. berghei ANKA, with no toxicity. The findings from the present study provide scientific evidence supporting the use of S. pinnata seeds in the development of new drugs for malaria treatment. Additional studies are needed to isolate and identify the active compounds as well as to understand the mechanism of inhibition.

Indexed as

AnacardiaceaeAntimalarialsAnimalsMicePlant ExtractsPlasmodium bergheiSeedsAntimalarialsPlant ExtractsAntimalarial activityMalariaPlasmodium bergheiSpondias pinnataToxicity

Identifiers

PMID35296314
PMCPMC8928678
OpenAlexW4220950151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.